ZOM - Earnings announcements

ANN ARBOR, MI / ACCESSWIRE / November 7, 2024 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the third quarter ended September 30, 2024."We are very pleased with our performance, highlighted by record third quarter revenue and a double-digit increase compared to last year, which demonstrates that the execution of our growth initiatives has continued to pay dividends. As expected, PulseVet® capital sales rebounded during the third quarter bolstered by a full-strength sales team in the U.S. and continued positive

ANN ARBOR, MI / ACCESSWIRE / October 23, 2024 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, November 7, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its thirdquarter ended September 30, 2024. A question-and-answer session will follow management's prepared remarks.Event: Zomedica Corp. Q3 2024 Financial Results Conference CallDate: Thursday, November 7, 2024Time: 4:30 p.m. Eastern TimeLive Call: +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (Internat

Diagnostic revenues up 68% year-over-year ANN ARBOR, MI / ACCESSWIRE / August 14, 2024 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the second quarter ended June 30, 2024."We are pleased with the progress in the quarter, which represents the highest second quarter for the Company to date. We saw significant growth in our diagnostic product revenue, reflecting growing adoption of our TRUFORMA® and VETGuardian® products. We also enjoyed substantial growth in consumable products, reflecting the robust usage of ou

ANN ARBOR, MI / ACCESSWIRE / August 1, 2024 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Wednesday, August 14, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its second quarter ended June 30, 2024. A question-and-answer session will follow management's prepared remarks.Event: Zomedica Corp. Q2 2024 Financial Results Conference CallDate: Wednesday, August 14, 2024Time: 4:30 p.m. Eastern TimeLive Call: +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (International

Performance Sets New Record for First Quarter RevenueANN ARBOR, MI / ACCESSWIRE / May 9, 2024 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the first quarter ended March 31, 2024.2024 First Quarter Financial HighlightsRevenue for the first quarter of 2024 grew 14% to $6.3 million, compared to first quarter 2023 revenue, driven by 9% growth over the prior year in the Therapeutic Devices segment and 86% growth over the prior year in the Diagnostics segment.Consumable revenues grew to $4.0 million, up 7% over firs

ANN ARBOR, MI / ACCESSWIRE / April 30, 2024 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, May 9th, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its first quarter ended March 31, 2024. A question-and-answer session will follow management's prepared remarks.Event: Zomedica Corp. Q1 2024 Financial Results Conference CallDate: Thursday, May 9th, 2024Time: 4:30 p.m. Eastern TimeLive Call: +1-888-886-7786 (U.S. Toll-Free) or +1-416-764-8658 (International)Webca

ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for equine and companion animals, today reported consolidated financial results for the fourth quarter and year-ended December 31, 2023. All figures are in US dollars unless otherwise stated."The fourth quarter capped off another record quarter and year for Zomedica. On the strength of our highest revenue quarter ever, we grew full year revenue by over 33%, due to early adoption of newly launched products in our Diagnostics segment, and continued strength in our Therapeutic Devices segment," comment

ANN ARBOR, MI / ACCESSWIRE / March 20, 2024 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Monday, April 1st, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its fourth quarter and full year ended December 31, 2023. A question-and-answer session will follow management's prepared remarks.Event: Zomedica Corp. Q4 and Full Year 2023 Financial Results Conference CallDate: Monday, April 1, 2024Time: 4:30 p.m. Eastern TimeLive Call: +1-877-407-0789 (U.S. Toll-Free) or +1-201

ANN ARBOR, MI / ACCESSWIRE / January 17, 2024 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today provided a business update and will be hosting a conference call.Fourth Quarter Financial HighlightsRevenue for the fourth quarter of 2023 is expected to be over $7 million, a new record for the Company, compared to record fourth quarter 2022 revenue of $6.2 million, primarily driven by strong performance across many product lines, highlighted by a record quarter in the Therapeutic Device segment.Full Year 2023 Financial HighlightsRevenue for 2023 is expected to

ANN ARBOR, MI / ACCESSWIRE / January 10, 2024 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced that it will be hosting a conference call on Wednesday, January 17, 2024 at 4:30 p.m. ET.Management will provide a business update, including preliminary 2023 revenue and cash position, as well as other operational highlights during the call. In addition, the Company will discuss the upcoming Share Consolidation ("reverse stock split") and other matters related to a Special Virtual-Only Meeting of Shareholders to be held on February 28, 2024, at 1:00 p.m

ANN ARBOR, MI / ACCESSWIRE / November 13, 2023 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today reported consolidated financial results for the quarter ended September 30, 2023.2023 Third Quarter Financial HighlightsRevenues for the third quarter of 2023 grew 31% to $6.3 million, compared to third quarter 2022 revenues of $4.8 million, primarily driven by:Growth in the Therapeutic Devices segment, where revenues from PulseVet® and Assisi® product sales came in at $6.0 million, reflecting an increase of 28% over third quarter 2022 revenues;Growth in the Diagnostic seg

ANN ARBOR, MI / ACCESSWIRE / November 2, 2023 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for companion animals, will host a conference call and audio-only webcast on Monday, November 13, 2023 at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its third quarter ended September 30, 2023. A question-and-answer session will follow management's prepared remarks.Event: Zomedica Q3 2023 Financial Results Conference CallDate: Monday, November 13, 2023Time: 4:30 p.m. Eastern TimeLive Call: +1-877-407-0789 (U.S. Toll-Free) or +1-201-689-8562 (International)Webcast: http

ANN ARBOR, MI / ACCESSWIRE / August 4, 2023 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, will host a conference call and audio-only webcast on Thursday, August 10, 2023 at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its second quarter ending June 30, 2023. A question-and-answer session will follow management's prepared remarks.Event: Zomedica Q2 2023 Financial Result Conference CallDate: Thursday, August 10, 2023Time: 4:30 p.m. Eastern TimeLive Call: +1-888-886-7786 (U.S. Toll-Free) or +1-416-764-8658 (International)Webcast: https://viavid.webcasts.

New podcast series shines a spotlight on undervalued small-cap and microcap stocksORLANDO, FL / ACCESSWIRE / August 2, 2023 / RedChip Companies, a renowned international investor relations firm specializing in microcap and small-cap companies,announce the launch of its much-anticipated podcast series, "Small Stocks, Big Money."Hosted by RedChip CEO Dave Gentry and Associate Director Barrett Boone, the "Small Stocks, Big Money" podcast aims to offer a first-hand look at undiscovered small-cap and microcap stocks before they catch the attention of bigger Wall Street players. The series features in-depth interviews with executives from some of the top names in smaller cap stocks, providing list

ANN ARBOR, MI / ACCESSWIRE / May 2, 2023 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, will host a conference call and audio-only webcast on Thursday, May 11, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its first quarter ending March 31, 2023. A question-and-answer session will follow management's prepared remarks.Event: Zomedica Q1 2023 Financial Result Conference CallDate: Wednesday, May 11, 2023Time: 4:30 p.m. Eastern TimeLive Call: +1-877-407-0789 (U.S. Toll-Free) or +1-201-689-8562 (International)Webcast: https://callme.viavid.com/viavid/?cal

ORLANDO, FL / ACCESSWIRE / March 31, 2023 / RedChip Companies will air a new interview with Zomedica Corp. (NYSE:ZOM) on The RedChip Money Report® on Bloomberg TV, this Saturday, April 1, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the Zomedica interview in its entirety at: https://www.zomedicainfo.com/interview_accessAbout The RedChip Money Report®The RedChip Money Report® is produced by RedChip Companies Inc., an international Investor Relations and media firm with 30 years' experience focused on Discovering Tomorrow's Blue Chips Today™. "The RedChip Money Report®" delivers insightful commentary on small-cap investing, inter

ANN ARBOR, MI / ACCESSWIRE / March 8, 2023 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, will host a conference call and audio-only webcast on Wednesday, March 15, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its fourth quarter and fiscal year ended December 31, 2022. A question-and-answer session will follow management's prepared remarks.Event:Zomedica Q4 and Fiscal Year 2022 Financial Results Conference CallDate:Wednesday, March 15, 2023Time:4:30 p.m. Eastern TimeLive Call:+1-877-407-0789 (U.S. Toll-Free) or +1-201-689-8562 (International)Webcast

ANN ARBOR, MI / ACCESSWIRE / February 9, 2023 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today reported its preliminary unaudited results for the fourth quarter and year ended 2022.Preliminary (unaudited) Fourth Quarter and Full Year 2022 Results:Revenue for the fourth quarter of 2022 is expected to be approximately $6.0-$6.2 million, an increase of 46-51% compared to the same prior year period, primarily driven by an increase in PulseVet® sales and the inclusion of the recently acquired Assisi® products.Revenue for the year ended 2022 is expected to be approximately

ORLANDO, FL / ACCESSWIRE / February 8, 2023 / RedChip Companies will air a new interview with Zomedica Corp. (NYSE:ZOM) ("Zomedica" or "Company") on The RedChip Money Report® on Bloomberg TV, this Saturday, February 11, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Interview highlights:In the exclusive RedChip Money Report interview, Zomedica's CEO Larry Heaton discusses how the Company is improving pet care and providing new business opportunities for vets, the current product line, the ability to acquire innovative technologies, and much more.Access this interview in its entirety at https://www.zomedicainfo.com/interview_accessAbout

ORLANDO, FL / ACCESSWIRE / January 25, 2023 / RedChip Companies is pleased to announce its CEO, Dave Gentry, was recently welcomed as a member of the Forbes Business Council.The Forbes Business Council committee invited Gentry to join the elite group of business leaders in recognition of his passion for helping entrepreneurs achieve success. The invitation-only community is made up of successful business owners and executives who have been chosen based on their accomplishments and experience.As a member, Gentry will be able to leverage the Forbes Business Council's collective resources to help foster growth in the RedChip Companies community. He will also be able to participate in exclusive